(Q50735158)

18 March 2018

title

Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? (English)

1 reference

18 March 2018

1 reference

Yoshihiro Tominaga

1

1 reference

18 March 2018

Daijyo Inaguma

2

1 reference

18 March 2018

Susumu Matsuoka

3

1 reference

18 March 2018

Hideki Tahara

4

1 reference

18 March 2018

Kazutaka Kukita

5

1 reference

18 March 2018

Satoshi Kurihara

6

1 reference

18 March 2018

Noritaka Onoda

7

1 reference

18 March 2018

Yoshinari Tsuruta

8

1 reference

18 March 2018

Syuichi Tsutsui

9

1 reference

18 March 2018

Kazumichi Ohta

10

1 reference

18 March 2018

Morimasa Kuwahara

11

1 reference

18 March 2018

Motoko Tanaka

12

1 reference

18 March 2018

Yoshiki Nishizawa

13

1 reference

18 March 2018

PTG study group

14

1 reference

18 March 2018

publication date

1 April 2006

1 reference

18 March 2018

Therapeutic Apheresis and Dialysis

published in

1 reference

18 March 2018

volume

10

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

198-204

1 reference

18 March 2018

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Control of uremic bone disease: role of vitamin D analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Clinical factors influencing sensitivity and response to epoetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Inflammation modifies lipid-mediated renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Surgical management of secondary hyperparathyroidism in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients--the Japanese strategy. Japanese Working Group on PEIT of Parathyroid, Tokyo, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00364.X

10.1111/J.1744-9987.2006.00364.X

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

16684224

1 reference

18 March 2018